Enterprise Value
282M
Cash
327.4M
Avg Qtr Burn
-22.28M
Short % of Float
11.41%
Insider Ownership
13.06%
Institutional Own.
70.63%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|